Dental sleep medicine is a part of dentistry that deals with using oral appliances, therapies, and medications to treat sleep-related issues like snoring, teeth grinding (bruxism), upper airway resistance syndrome (UARS), and sleep apnea. Bruxism is when a person grinds their teeth and clenches their jaws during sleep. UARS is a sleep problem where there's difficulty breathing during sleep due to the airway getting narrow when the muscles relax. Sleep apnea is a condition where a person temporarily stops breathing or has shallow breaths during sleep.
According to the American Sleep Apnea Association, the average adult should get 8 or 8.5 hours of sleep a night, with at least seven hours being the minimum for most people. However, a survey by the Center for Disease Control found that the percentage of Americans aged 25 to 64 sleeping six hours or less a night increased from 20% in 1985 to 30% in 2004. The American Academy of Dental Sleep Medicine estimates that almost 30 million adults in the U.S. have obstructive sleep apnea. This creates a substantial market, especially when considering those dealing with other sleep issues like snoring.
The market for dental sleep medicine and devices is expanding quickly. The primary reason for this growth is the significant number of people with unaddressed sleep-related health needs and an increasing awareness of sleep disorders. Lifestyle factors, such as lack of exercise, long working hours, and exposure to noise and light pollution, also contribute to the growing demand. The market is divided into treatment and diagnostics, with the treatment segment holding the majority at 61.42% and growing at a rate of 8.74% annually. The rise in awareness and the increasing number of people seeking solutions for sleep problems are driving the market's growth.
Covid 19 Analysis Coronavirus COVID-19's Impact: Since the emergence of the COVID-19 virus in December 2019, the disease has spread to nearly every country on the planet, prompting the World Health Organization to declare it a public health emergency. The global effects of the coronavirus illness 2019 (COVID-19) are already being felt, and the dental sleep medicine market trends will be substantially impacted in 2021. Flight cancellations, travel restrictions, and quarantines, restaurants closing, all indoor/outdoor events being limited, over forty nations declaring states of emergency, major supply chain slowdowns, and stock market volatility have all been impacted by the COVID-19 epidemic.
In October 2023, a clinical-stage pharmaceutical company specializing in oral pharmacologic therapies for obstructive sleep apnea (OSA) and other sleep disorders called Apnimed, Inc. announced a new partnership. They formed a joint venture with Shionogi & Co., Ltd., one of the world’s leading pharmaceutical companies which is based in Japan.
In June 2023, Torch Dental, a major dental procurement platform, partnered with the American Academy of Dental Sleep Medicine (AADSM). This move was widely regarded as an important milestone since each party brought its own knowledge base together to enhance dental sleep medicine through innovative solutions, education, and practice management that will help AADSM members gain some unique benefits.
New West Dental Lab launched EndSnorZ Sleep Appliance in December 2022 as it seeks to diversify its range of mandibular advancement devices (MADs). This latest inclusion gives dentists using 3D-printing technology the possibility of producing individualized products for patients. The appliance offers adjustable increments of up to 0.5 mm over a 10 mm range, thereby providing specific treatment options that are both precise and tailored to meet each patient’s needs.
In the projection period of 2021 to 2028, the dental sleep medicine market will benefit from increased research and development, as well as linked solutions and cloud-based systems, as well as personalized and customized solutions.
Some factors that may impede the growth of the dental sleep medicine market include a lack of patient awareness and expensive treatment prices.
The high cost and scarcity of sleep laboratories, as well as their lack of efficacy and efficiency, would restrict the expansion of the dental sleep medicine market, whereas inadequate standardization, lack of knowledge, and discomfort may provide a challenge to the dental sleep medicine market's growth.
Cumulative Growth Analysis
Unmet medical demands are driving the growth of the dental sleep medication industry. Obstructive sleep apnea affects over 30 million individuals in the United States, according to the American Academy of Dental Sleep Medicine. Sleep is harmed by sedentary lifestyles, extended working hours, noise exposure, and light pollution such as the usage of bright neon lights. Due to its safety, efficiency, and efficacy when compared to procedures and medicines, positive air pressure treatment has the greatest dental sleep medicine market share.
The gold standard in dental sleep medicine diagnosis is polysomnography and respiratory polygraphy. However, because of their simplicity of use, efficiency, and accuracy, the emergence of portable and home-based devices is threatening their market dominance. The primary reason for the increase in efficiency and accuracy is the employment of sophisticated software in these products. Oximetry is more portable and quicker, but the findings are less sensitive and accurate.
Value Chain Analysis
According to the reports, the global dental sleep medicine market is segmented on the basis of treatment, diagnostics, end-user, and region. Positive airway pressure (PAP) therapy, oral and nasal devices, airway systems, medicines, surgery, and other devices are all part of the treatment section. Polysomnography and respiratory polygraphy, home oximetry, and actigraphy are all part of the diagnostics section. The dental sleep medicine market is divided into three categories based on the end-user: hospitals, sleep labs, and homes. In 2016, the treatment segment had the biggest dental sleep medicine global market share of 61.42 percent, and it is anticipated to increase at a CAGR of 8.74 percent from 2016 to 2022. In 2016, hospitals and sleep laboratories had the biggest dental sleep medicine global market share of 57.1 percent, while North America had the largest market share of USD 2,849.44 million.
Dental Sleep Medicine Market Segment Insights
The dental sleep medicine market is segmented on the basis of treatment, diagnostics, end-user, and region. The global dental sleep medicine market is expected to witness decent growth during the forecast period.
Based on the application, the dental sleep medicine market is segmented into positive airway pressure (PAP) therapy, oral and nasal devices, airway systems, medicines, surgery, and other devices.
Based on the propulsion types, the dental sleep medicine market is segmented into hospitals, sleep labs, and homes.
Regional Analysis
According to the reports, on the basis of region, the global dental sleep medicine market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. In 2016, North America was the world's largest market for dental sleep medicine. Because of its high per capita income, superior reimbursement policies for medical equipment, and larger healthcare industry, the United States leads the North American market. The expansion of the North American market is also fueled by the concentration of major medical device makers in the United States. In 2016, Europe was the world's second-largest market for dental sleep medicine. The emerging regions, notably the Asia Pacific and the Middle East, and Africa, are projected to see the greatest growth for high-tech and low-tech dental sleep medication products throughout the projection period due to huge unmet demand.
Competitive landscape
The global dental sleep medicine market is highly fragmented due to the presence of prominent players in the market. Mergers, R&D, partnerships, and other tactics used by market players to get a foothold in this Market organizations are examples of specific methods used by market players to gain a foothold in the Dental Sleep Medicine Market.
Major Key Players
The following report comprises of –
2018, April- The American Academy of Dental Sleep Medicine, a leading national dentists' organization, has announced the AADSM Mastery Program, which will ensure that dentists have the necessary skills and training to provide patients with sleep-related breathing disorders such as snoring and obstructive sleep apnea (OSA) with proper oral appliance therapy (OAT).
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)